Eckert & Ziegler Strahlen- und Medizintechnik AG

Earnings Release • Nov 9, 2004

News Details

Corporate | 9 November 2004 07:45

Eckert & Ziegler: 42% Sales Increase in Third Quarter. Strong Growth in the …

Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Eckert & Ziegler: 42% Sales Increase in Third Quarter. Strong Growth in the Therapy Segment Berlin, 09 November 2004. Eckert & Ziegler AG (ISIN DE0005659700), a specialist in medical and industrial radiation technology, posted sales of 8.5 million EUR in the third quarter of 2004, an increase of 42% over the same quarter of last year and a cumulative revenue increase for the first nine months of 34% from 18.9 in the previous year to now 25.3 million EUR. Income from ongoing business activities rose by 27% to 0.5 million EUR compared to the 2004 half year results. Adjusted income after taxes, including the NEMOD deconsolidation, reached 1,7 million EUR for the nine-month period, which corresponds to an EPS of 0,54 EUR. As in previous quarters, growth was primarily driven by the radiation therapy segment, which doubled in revenue. For the current business year, the Executive Board anticipates sales of around 36 million EUR and a profit per share of approximately 0.70 EUR. Your contact for inquiries: Eckert & Ziegler AG Karolin Riehle Investor Relations Robert-Rössle-Str. 10 D-13125 Berlin Phone: +49 (0)30 / 94 10 84-138 http://www.ezag.com end of message, (c)DGAP 09.11.2004 ——————————————————————————– WKN: 565970; ISIN: DE0005659700; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart 090745 Nov 04